vs
AlTi Global, Inc.（ALTI）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
AlTi Global, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.1倍（$86.6M vs $75.5M），AlTi Global, Inc.同比增速更快（87.0% vs 27.7%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-52.2M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 30.6%）
该公司原名Cristal Global，是全球第二大二氧化钛生产商，同时也是钛化学品的龙头供应商，由原国家二氧化钛有限公司与 Millennium Chemicals 合并组建而成，总部设于沙特阿拉伯吉达。该公司是全球第五大二氧化钛原料生产商Bemax的重要股东。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
ALTI vs PBYI — 直观对比
营收规模更大
ALTI
是对方的1.1倍
$75.5M
营收增速更快
ALTI
高出59.3%
27.7%
自由现金流更多
PBYI
多$66.6M
$-52.2M
两年增速更快
PBYI
近两年复合增速
30.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $86.6M | $75.5M |
| 净利润 | $-13.1M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | -2.1% | 22.7% |
| 净利率 | -15.1% | — |
| 营收同比 | 87.0% | 27.7% |
| 净利润同比 | 75.6% | — |
| 每股收益（稀释后） | — | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALTIPBYI
| Q4 25 | $86.6M | $75.5M | ||
| Q3 25 | $57.2M | $54.5M | ||
| Q2 25 | $53.1M | $52.4M | ||
| Q1 25 | $58.0M | $46.0M | ||
| Q4 24 | $46.3M | $59.1M | ||
| Q3 24 | $51.8M | $80.5M | ||
| Q2 24 | $49.5M | $47.1M | ||
| Q1 24 | $50.8M | $43.8M |
净利润ALTIPBYI
| Q4 25 | $-13.1M | — | ||
| Q3 25 | $-84.1M | $8.8M | ||
| Q2 25 | $-24.4M | $5.9M | ||
| Q1 25 | $1.9M | $3.0M | ||
| Q4 24 | $-53.8M | — | ||
| Q3 24 | $-72.5M | $20.3M | ||
| Q2 24 | $-6.4M | $-4.5M | ||
| Q1 24 | $29.7M | $-4.8M |
毛利率ALTIPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率ALTIPBYI
| Q4 25 | -2.1% | 22.7% | ||
| Q3 25 | -49.8% | 17.6% | ||
| Q2 25 | -56.7% | 12.7% | ||
| Q1 25 | -23.3% | 8.7% | ||
| Q4 24 | -42.7% | 22.6% | ||
| Q3 24 | -18.4% | 27.4% | ||
| Q2 24 | -30.2% | -4.6% | ||
| Q1 24 | -28.9% | -5.3% |
净利率ALTIPBYI
| Q4 25 | -15.1% | — | ||
| Q3 25 | -147.0% | 16.2% | ||
| Q2 25 | -45.9% | 11.2% | ||
| Q1 25 | 3.3% | 6.5% | ||
| Q4 24 | -116.1% | — | ||
| Q3 24 | -140.0% | 25.2% | ||
| Q2 24 | -12.9% | -9.6% | ||
| Q1 24 | 58.4% | -11.0% |
每股收益（稀释后）ALTIPBYI
| Q4 25 | — | $0.26 | ||
| Q3 25 | — | $0.17 | ||
| Q2 25 | $-0.33 | $0.12 | ||
| Q1 25 | $-0.04 | $0.06 | ||
| Q4 24 | $-0.71 | $0.40 | ||
| Q3 24 | $-0.88 | $0.41 | ||
| Q2 24 | $-0.18 | $-0.09 | ||
| Q1 24 | $0.18 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $41.2M | $97.5M |
| 总债务越低越好 | $883.0K | $22.7M |
| 股东权益账面价值 | $600.1M | $130.3M |
| 总资产 | $1.2B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.00× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资ALTIPBYI
| Q4 25 | $41.2M | $97.5M | ||
| Q3 25 | $35.8M | $94.4M | ||
| Q2 25 | $42.4M | $96.0M | ||
| Q1 25 | $52.8M | $93.2M | ||
| Q4 24 | $64.4M | $101.0M | ||
| Q3 24 | $220.6M | $96.7M | ||
| Q2 24 | $60.0M | $96.8M | ||
| Q1 24 | $134.2M | $107.2M |
总债务ALTIPBYI
| Q4 25 | $883.0K | $22.7M | ||
| Q3 25 | $586.0K | $34.0M | ||
| Q2 25 | $673.0K | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | $0 | $68.0M | ||
| Q3 24 | $128.4M | $79.3M | ||
| Q2 24 | $164.0M | $90.7M | ||
| Q1 24 | $183.7M | $102.0M |
股东权益ALTIPBYI
| Q4 25 | $600.1M | $130.3M | ||
| Q3 25 | $607.2M | $115.3M | ||
| Q2 25 | $685.4M | $104.7M | ||
| Q1 25 | $665.2M | $97.1M | ||
| Q4 24 | $658.4M | $92.1M | ||
| Q3 24 | $707.0M | $71.1M | ||
| Q2 24 | $540.2M | $48.5M | ||
| Q1 24 | $510.9M | $51.0M |
总资产ALTIPBYI
| Q4 25 | $1.2B | $216.3M | ||
| Q3 25 | $1.2B | $202.9M | ||
| Q2 25 | $1.2B | $194.9M | ||
| Q1 25 | $1.2B | $196.2M | ||
| Q4 24 | $1.3B | $213.3M | ||
| Q3 24 | $1.4B | $220.7M | ||
| Q2 24 | $1.3B | $205.0M | ||
| Q1 24 | $1.3B | $214.1M |
负债/权益比ALTIPBYI
| Q4 25 | 0.00× | 0.17× | ||
| Q3 25 | 0.00× | 0.30× | ||
| Q2 25 | 0.00× | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | 0.00× | 0.74× | ||
| Q3 24 | 0.18× | 1.12× | ||
| Q2 24 | 0.30× | 1.87× | ||
| Q1 24 | 0.36× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-51.4M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-52.2M | $14.4M |
| 自由现金流率自由现金流/营收 | -60.3% | 19.1% |
| 资本支出强度资本支出/营收 | 0.9% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流ALTIPBYI
| Q4 25 | $-51.4M | $14.4M | ||
| Q3 25 | $-53.5M | $9.7M | ||
| Q2 25 | $-19.9M | $14.1M | ||
| Q1 25 | $-30.2M | $3.6M | ||
| Q4 24 | $-50.7M | $15.6M | ||
| Q3 24 | $-4.9M | $11.0M | ||
| Q2 24 | $-30.2M | $1.0M | ||
| Q1 24 | $-15.5M | $11.2M |
自由现金流ALTIPBYI
| Q4 25 | $-52.2M | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | $-20.0M | $14.1M | ||
| Q1 25 | $-31.0M | $3.6M | ||
| Q4 24 | $-58.2M | $15.6M | ||
| Q3 24 | $-9.4M | $11.0M | ||
| Q2 24 | $-31.2M | $1.0M | ||
| Q1 24 | $-15.7M | — |
自由现金流率ALTIPBYI
| Q4 25 | -60.3% | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | -37.6% | 26.8% | ||
| Q1 25 | -53.4% | 7.7% | ||
| Q4 24 | -125.7% | 26.4% | ||
| Q3 24 | -18.2% | 13.7% | ||
| Q2 24 | -63.2% | 2.1% | ||
| Q1 24 | -30.9% | — |
资本支出强度ALTIPBYI
| Q4 25 | 0.9% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 1.3% | 0.1% | ||
| Q4 24 | 16.3% | 0.0% | ||
| Q3 24 | 8.7% | 0.0% | ||
| Q2 24 | 2.2% | 0.0% | ||
| Q1 24 | 0.4% | 0.0% |
现金转化率ALTIPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | -15.80× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.52× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALTI
| Management Advisory Fees | $51.1M | 59% |
| Other | $32.7M | 38% |
| Distributions From Investments | $2.9M | 3% |
PBYI
暂无分部数据
